Literature DB >> 17524759

Kidney disease, Framingham risk scores, and cardiac and mortality outcomes.

Daniel E Weiner1, Hocine Tighiouart, John L Griffith, Essam Elsayed, Andrew S Levey, Deeb N Salem, Mark J Sarnak.   

Abstract

BACKGROUND: The Framingham equations were developed to predict incident coronary heart disease. It remains unknown how the presence of chronic kidney disease affects their performance.
METHODS: Individuals without preexisting cardiovascular disease aged 45 to 74 years from the Atherosclerosis Risk in Communities and Cardiovascular Health Studies were analyzed. Using sex- and race-specific Cox models, we evaluated the 5-year risk of coronary heart disease and mortality events associated with both chronic kidney disease and Framingham risk score, the absolute risk of events caused by kidney disease, and model discrimination.
RESULTS: Among 15,717 subjects, 756 (4.8%) had kidney disease. The Framingham risk score independently predicted cardiac and mortality events in all subgroups, whereas kidney disease predicted events in all subgroups except cardiac events in white women. After adjustment for traditional risk factors, the increase in cardiac and mortality events per 1000 person-years attributable to kidney disease was 4.3 and 13.7 for white men, 16.1 and 40.5 for African American men, 1.2 and 5.8 for white women, and 13.6 and 14.2 for African American women, respectively. This represented an additional 17,000 and 12,000 cardiac events and 63,000 and 19,000 deaths per year among whites and African Americans, respectively. Mortality rates attributable to kidney disease, diabetes, and smoking were comparable. Accounting for kidney disease improved discrimination for only mortality outcomes in white men and African American women.
CONCLUSIONS: Chronic kidney disease in a community-based population is an important predictor of cardiac and mortality events, particularly in African Americans, but it does not improve discrimination of Framingham equations.

Entities:  

Mesh:

Year:  2007        PMID: 17524759     DOI: 10.1016/j.amjmed.2006.05.054

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  The effect of including cystatin C or creatinine in a cardiovascular risk model for asymptomatic individuals: the multi-ethnic study of atherosclerosis.

Authors:  Hiroki Ito; Ivan V Pacold; Ramon Durazo-Arvizu; Kiang Liu; Michael G Shilipak; David C Goff; Russell P Tracy; Holly Kramer
Journal:  Am J Epidemiol       Date:  2011-08-30       Impact factor: 4.897

2.  Comparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Devin M Mann; Alain G Bertoni; Daichi Shimbo; Mercedes R Carnethon; Haiying Chen; Nancy Swords Jenny; Paul Muntner
Journal:  Am J Epidemiol       Date:  2010-04-07       Impact factor: 4.897

3.  Cardiovascular health of HIV-infected African-American women at the Miriam Hospital Immunology Center in Providence, RI.

Authors:  Dalila Zachary; Fizza S Gillani; Nida Najfi; Ryan Casarella; Karen Tashima
Journal:  Med Health R I       Date:  2012-06

4.  Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.

Authors:  Jia Sun; Jonas Axelsson; Anna Machowska; Olof Heimbürger; Peter Bárány; Bengt Lindholm; Karin Lindström; Peter Stenvinkel; Abdul Rashid Qureshi
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-08       Impact factor: 8.237

5.  Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD.

Authors:  Marta Gracia; Àngels Betriu; Montserrat Martínez-Alonso; David Arroyo; María Abajo; Elvira Fernández; José M Valdivielso
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-14       Impact factor: 8.237

Review 6.  Cardiovascular risk prediction in people with chronic kidney disease.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-11       Impact factor: 2.894

7.  Cardiovascular risk assessment: addition of CKD and race to the Framingham equation.

Authors:  Paul E Drawz; Sarah Baraniuk; Barry R Davis; Clinton D Brown; Pedro J Colon; Aloysius B Cujyet; Richard A Dart; James F Graumlich; Mario A Henriquez; Jamaluddin Moloo; Mohammed G Sakalayen; Debra L Simmons; Carol Stanford; Mary Ellen Sweeney; Nathan D Wong; Mahboob Rahman
Journal:  Am Heart J       Date:  2012-10-29       Impact factor: 4.749

8.  Kidney function and estimated vascular risk in patients with primary dyslipidemia.

Authors:  Konstantinos Tziomalos; Emmanuel S Ganotakis; Irene F Gazi; Devaki R Nair; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2009-06-16

9.  Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort).

Authors:  Jane F Ferguson; Gregory J Matthews; Raymond R Townsend; Dominic S Raj; Peter A Kanetsky; Matthew Budoff; Michael J Fischer; Sylvia E Rosas; Radhika Kanthety; Mahboob Rahman; Stephen R Master; Atif Qasim; Mingyao Li; Nehal N Mehta; Haiqing Shen; Braxton D Mitchell; Jeffrey R O'Connell; Alan R Shuldiner; Weang Kee Ho; Robin Young; Asif Rasheed; John Danesh; Jiang He; John W Kusek; Akinlolu O Ojo; John Flack; Alan S Go; Crystal A Gadegbeku; Jackson T Wright; Danish Saleheen; Harold I Feldman; Daniel J Rader; Andrea S Foulkes; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2013-05-30       Impact factor: 24.094

10.  Association between N-terminal Pro-Brain Natriuretic Peptide levels, glomerular filtration rate, and heart failure in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Daneyal Syed; Stephanie Peshenko; Kiang Liu; Ramon Durazo-Arvizu; Sylvia E Rosas; Michael Shlipak; Mark Sarnak; David Jacobs; David Sickovick; João Lima; Richard Kronmal; Holly Kramer
Journal:  J Integr Cardiol       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.